Shilpa Medicare Commissions Integrated ADC Drug Facility; Net Profit Surges 642%
Shilpa Medicare commissions an integrated ADC drug substance GMP facility in Dharwad, positioning it as a global CDMO partner with ₹11,561 Cr market valuation.
ALFA News
Straight from the exchange filing
Shilpa Medicare commissions an integrated ADC drug substance GMP facility in Dharwad, positioning it as a global CDMO partner with ₹11,561 Cr market valuation.